Editorial Recommendations of the Month
Key articles from high impact journals in last month
Febuary 2023
Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study
Melek Simsek, Femke Schepers, Sigal Kaplan, Dirk van Asseldonk, Petra van Boeckel, Paul Boekema, Gerard Dijkstra, Herma Fidder, Ingrid Gisbertz, Frank Hoentjen, Bindia Jharap, Frank Kubben, Marleen de Leest, Maarten Meijssen, Ana Petrak, Else van de Poel, Maurice Russel, Adriaan A van Bodegraven, Chris J J Mulder, Nanne de Boer
Published on 25 Jan 2023, Journal of Crohn's & colitis.
GATA6-AS1 regulates intestinal epithelial mitochondrial functions, and its reduced expression is linked to intestinal inflammation and less favorable disease course in ulcerative colitis (UC)
Katya E Sosnovski, Tzipi Braun, Amnon Amir, Danielle Moshel, Marina BenShoshan, Kelli L VanDussen, Nina Levhar, Haya Abbas-Egbariya, Katia Beider, Rakefet Ben-Yishay, Syed Asad Ali , Sean R Moore, Subra Kugathasan, Ifat Abramovich, Efrat Glick Saar, Batya Weiss, Iris Barshack, Eyal Gottlieb, Tamar Geiger, Shomron Ben-Horin, Igor Ulitsky, Jeffrey S Hyams, Lee A Denson, Yael Haberman
Published on 25 Jan 2023, Journal of Crohn's & colitis.
A compendium of mucosal molecular characteristics provides novel perspectives on the treatment of ulcerative colitis
Min-Jing Chang, Jia-Wei Hao, Jun Qiao, Miao-Ran Chen, Qian Wang, Qi Wang, Sheng-Xiao Zhang, Qi Yu, Pei-Feng He
Published on 23 Jan 2023, Journal of Crohn's & colitis
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, Jack Satsangi, Nik Ding, Britta Siegmund, Geert D'Haens, Laurence Picon, Peter Bossuyt, Lucine Vuitton, Peter Irving, Stephanie Viennot, Christopher A Lamb, Richard Pollok, Filip Baert, Maria Nachury, Mathurin Fumery, Cyrielle Gilletta, Sven Almer, Shomron Ben-Horin, Yoram Bouhnik, Jean-Frederic Colombel, Erik Hertervig; GETAID and the SPARE-Biocycle research group
Published on 11 Jan 2023, The lancet. Gastroenterology & hepatology
Multicenter Study of Non-adherence to Self-Injectable Biologic Therapy in Patients
with IBD: Risk Factors and Outcomes
Accepted on 23 Jan 2023, Gastro Hep Advances
Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results from a Randomized, Phase 2b Study
William J Sandborn, Silvio Danese, Jaroslaw Leszczyszyn, Jacek Romatowski, Engin Altintas, Elena Peeva, Mina Hassan-Zahraee, Michael S Vincent, Padmalatha S Reddy, Christopher Banfield, Mikhail Salganik, Anindita Banerjee, Jeremy D Gale, Kenneth E Hung
Published on 6 Jan 2023, Clin Gastroenterol Hepatol
Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease
Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C Pollok; POP-IBD study group
Published on 10 Jan 2023, Alimentary pharmacology & therapeutics.
Venous thromboembolism risk stratification for patients undergoing surgery for IBD using a novel six factor scoring system using NSQIP-IBD registry
Ju Yong Cheong, Tara M Connelly, Tara Russell, Michael Valente, Anuradha Bhama, Amy Lightner, Tracy Hull, Scott R Steele, Stefan D Holubar
Published on 16 Jan 2023, ANZ journal of surgery
Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease
Michael Logan, Mary MacKinder, Clare Martha Clark, Aikaterini Kountouri, Mwansa Jere, Umer Zeeshan Ijaz, Richard Hansen, Paraic McGrogan, Richard K Russell, Konstantinos Gerasimidis
Published in May 2022, BioMed Central gastroenterology.